Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Natural Killer Cell Therapy market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Natural Killer Cell Therapy market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027. Segmented by Category NK Cell Therapies NK Cell Directed Antibodies Segmented by End User/Segment Cancer Gastrointestinal Diseases Others Segmented by Country North America United States Canada Mexico Europe Germany France UK Italy Russia Spain Asia Pacific China Japan Korea Southeast Asia India Australasia Central & South America Brazil Argentina Colombia Middle East & Africa Iran Israel Turkey South Africa Saudi Arabia Key manufacturers included in this survey Nkarta Therapeutics Nektar Therapeutics NantKwest Kiadis Pharma Innate Pharma SA Glycostem Therapeutics Fate Therapeutics Dragonfly Therapeutics Chipscreen Biosciences Affimed

List of Figures

Figure Natural Killer Cell Therapy Picture
Figure Global Natural Killer Cell Therapy Sales Value (Million USD) and Growth Rate (2016-2027)
Figure Global Natural Killer Cell Therapy Sales Value CAGR (2020-2027) by Region
Figure Global Natural Killer Cell Therapy Sales Value Market Share by Company, 2020
Figure Product Picture of NK Cell Therapies
Figure Product Picture of NK Cell Directed Antibodies
Figure Global Natural Killer Cell Therapy Sales Value Market Share by Category, 2020
Figure North America Natural Killer Cell Therapy Sales Value Market Share by Category, 2020
Figure Europe Natural Killer Cell Therapy Sales Value Market Share by Category, 2020
Figure Asia Pacific Natural Killer Cell Therapy Sales Value Market Share by Category, 2020
Figure Central & South America Natural Killer Cell Therapy Sales Value Market Share by Category, 2020
Figure Middle East & Africa Natural Killer Cell Therapy Sales Value Market Share by Category, 2020
Figure Natural Killer Cell Therapy in Cancer
Figure Global Natural Killer Cell Therapy Market: Cancer (2016-2021)
Figure Natural Killer Cell Therapy in Gastrointestinal Diseases
Figure Global Natural Killer Cell Therapy Market: Gastrointestinal Diseases (2016-2021)
Figure Natural Killer Cell Therapy in Others
Figure Global Natural Killer Cell Therapy Market: Others (2016-2021)
Figure Global Natural Killer Cell Therapy Sales Value Market Share by End User/Segment, 2020
Figure North America Natural Killer Cell Therapy Sales Value Market Share by End User/Segment, 2020
Figure Europe Natural Killer Cell Therapy Sales Value Market Share by End User/Segment, 2020
Figure Asia Pacific Natural Killer Cell Therapy Sales Value Market Share by End User/Segment, 2020
Figure Central & South America Natural Killer Cell Therapy Sales Value Market Share by End User/Segment, 2020
Figure Middle East & Africa Natural Killer Cell Therapy Sales Value Market Share by End User/Segment, 2020
Figure Global Natural Killer Cell Therapy Sales Value Market Share by Region (2016-2021)
Figure North America Natural Killer Cell Therapy Sales Value (Million USD) Status (2016-2021)
Figure Europe Natural Killer Cell Therapy Sales Value (Million USD) Status (2016-2021)
Figure Asia Pacific Natural Killer Cell Therapy Sales Value (Million USD) Status (2016-2021)
Figure Central & South America Natural Killer Cell Therapy Sales Value (Million USD) Status (2016-2021)
Figure Middle East & Africa Natural Killer Cell Therapy Sales Value (Million USD) Status (2016-2021)
Figure North America Natural Killer Cell Therapy Sales Value Market Share by Country, 2020
Figure United States Natural Killer Cell Therapy Sales Value (Million USD) Status (2016-2021)
Figure Canada Natural Killer Cell Therapy Sales Value (Million USD) Status (2016-2021)
Figure Mexico Natural Killer Cell Therapy Sales Value (Million USD) Status (2016-2021)

Table of Contents1 Product Introduction and Overview 1.1 Product Definition 1.2 Product Specification 1.3 Global Market Overview 1.3.1 Global Natural Killer Cell Therapy Market Status and Forecast (2016-2027) 1.3.2 Global Natural Killer Cell Therapy Sales Value CAGR by Region 1.4 Market Drivers, Inhibitors 1.4.1 Market Drivers 1.4.2 Market Inhibitors 1.4.3 COVID-19 Impact Analysis2 Global Natural Killer Cell Therapy Supply by Company 2.1 Global Natural Killer Cell Therapy Sales Value by Company 2.2 Natural Killer Cell Therapy Sales Area of Main Manufacturers 2.3 Trend of Concentration Rate3 Global and Regional Natural Killer Cell Therapy Market Status by Category 3.1 Natural Killer Cell Therapy Category Introduction 3.1.1 NK Cell Therapies 3.1.2 NK Cell Directed Antibodies 3.2 Global Natural Killer Cell Therapy Market by Category 3.3 North America: by Category 3.4 Europe: by Category 3.5 Asia Pacific: by Category 3.6 Central & South America: by Category 3.7 Middle East & Africa: by Category4 Global and Regional Natural Killer Cell Therapy Market Status by End User/Segment 4.1 Natural Killer Cell Therapy Segment by End User/Segment 4.1.1 Cancer 4.1.2 Gastrointestinal Diseases 4.1.3 Others 4.2 Global Natural Killer Cell Therapy Market by End User/Segment 4.3 North America: by End User/Segment 4.4 Europe: by End User/Segment 4.5 Asia Pacific: by End User/Segment 4.6 Central & South America: by End User/Segment 4.7 Middle East & Africa: by End User/Segment5 Global Natural Killer Cell Therapy Market Status by Region 5.1 Global Natural Killer Cell Therapy Market by Region 5.2 North America Natural Killer Cell Therapy Market Status 5.3 Europe Natural Killer Cell Therapy Market Status 5.4 Asia Pacific Natural Killer Cell Therapy Market Status 5.5 Central & South America Natural Killer Cell Therapy Market Status 5.6 Middle East & Africa Natural Killer Cell Therapy Market Status6 North America Natural Killer Cell Therapy Market Status 6.1 North America Natural Killer Cell Therapy Market by Country 6.2 United States 6.3 Canada 6.4 Mexico7 Europe Natural Killer Cell Therapy Market Status 7.1 Europe Natural Killer Cell Therapy Market by Country 7.2 Germany 7.3 France 7.4 UK 7.5 Italy 7.6 Russia 7.7 Spain8 Asia Pacific Natural Killer Cell Therapy Market Status 8.1 Asia Pacific Natural Killer Cell Therapy Market by Country 8.2 China 8.3 Japan 8.4 Korea 8.5 Southeast Asia 8.6 India 8.7 Australasia9 Central & South America Natural Killer Cell Therapy Market Status 9.1 Central & South America Natural Killer Cell Therapy Market by Country 9.2 Brazil 9.3 Argentina 9.4 Colombia10 Middle East & Africa Natural Killer Cell Therapy Market Status 10.1 Middle East & Africa Natural Killer Cell Therapy Market by Country 10.2 Iran 10.3 Israel 10.4 Turkey 10.5 South Africa 10.8 Saudi Arabia11 Major Downstream Customers Analysis 11.1 Customer One Analysis 11.2 Customer Two Analysis 11.3 Customer Three Analysis 11.4 Customer Four Analysis12 Global Natural Killer Cell Therapy Market Forecast by Category and by End User/Segment 12.1 Global Natural Killer Cell Therapy Sales Value Forecast (2022-2027) 12.2 Global Natural Killer Cell Therapy Forecast by Category 12.3 Global Natural Killer Cell Therapy Forecast by End User/Segment13 Global Natural Killer Cell Therapy Market Forecast by Region/Country 13.1 Global Natural Killer Cell Therapy Market Forecast by Region (2022-2027) 13.2 North America Market Forecast 13.3 Europe Market Forecast 13.4 Asia Pacific Market Forecast 13.5 Central & South America Market Forecast 13.6 Middle East & Africa Market Forecast14 Key Participants Company Information 14.1 Nkarta Therapeutics 14.1.1 Company Information 14.1.2 Natural Killer Cell Therapy Product Introduction 14.1.3 Nkarta Therapeutics Natural Killer Cell Therapy Sales Value, Gross Margin and Global Share (2019-2021) 14.1.4 SWOT Analysis 14.2 Nektar Therapeutics 14.2.1 Company Information 14.2.2 Natural Killer Cell Therapy Product Introduction 14.2.3 Nektar Therapeutics Natural Killer Cell Therapy Sales Value, Gross Margin and Global Share (2019-2021) 14.2.4 SWOT Analysis 14.3 NantKwest 14.3.1 Company Information 14.3.2 Natural Killer Cell Therapy Product Introduction 14.3.3 NantKwest Natural Killer Cell Therapy Sales Value, Gross Margin and Global Share (2019-2021) 14.3.4 SWOT Analysis 14.4 Kiadis Pharma 14.4.1 Company Information 14.4.2 Natural Killer Cell Therapy Product Introduction 14.4.3 Kiadis Pharma Natural Killer Cell Therapy Sales Value, Gross Margin and Global Share (2019-2021) 14.4.4 SWOT Analysis 14.5 Innate Pharma SA 14.5.1 Company Information 14.5.2 Natural Killer Cell Therapy Product Introduction 14.5.3 Innate Pharma SA Natural Killer Cell Therapy Sales Value, Gross Margin and Global Share (2019-2021) 14.5.4 SWOT Analysis 14.6 Glycostem Therapeutics 14.6.1 Company Information 14.6.2 Natural Killer Cell Therapy Product Introduction 14.6.3 Glycostem Therapeutics Natural Killer Cell Therapy Sales Value, Gross Margin and Global Share (2019-2021) 14.6.4 SWOT Analysis 14.7 Fate Therapeutics 14.7.1 Company Information 14.7.2 Natural Killer Cell Therapy Product Introduction 14.7.3 Fate Therapeutics Natural Killer Cell Therapy Sales Value, Gross Margin and Global Share (2019-2021) 14.7.4 SWOT Analysis 14.8 Dragonfly Therapeutics 14.8.1 Company Information 14.8.2 Natural Killer Cell Therapy Product Introduction 14.8.3 Dragonfly Therapeutics Natural Killer Cell Therapy Sales Value, Gross Margin and Global Share (2019-2021) 14.8.4 SWOT Analysis 14.9 Chipscreen Biosciences 14.9.1 Company Information 14.9.2 Natural Killer Cell Therapy Product Introduction 14.9.3 Chipscreen Biosciences Natural Killer Cell Therapy Sales Value, Gross Margin and Global Share (2019-2021) 14.9.4 SWOT Analysis 14.10 Affimed 14.10.1 Company Information 14.10.2 Natural Killer Cell Therapy Product Introduction 14.10.3 Affimed Natural Killer Cell Therapy Sales Value, Gross Margin and Global Share (2019-2021) 14.10.4 SWOT Analysis15 Conclusion16 Methodology